Exploiting Tertiary Lymphoid Structures in Rhabdomyosarcoma for Promoting Immunotherapy Response

Rhabdomyosarcoma is a devastating malignancy; outcomes for patients with high-risk disease are dismal and unlike many pediatric cancers, have not improved over the last 3 decades. Immunotherapy holds great potential for improving outcomes in sarcoma patients.